Lupin Limited
NSE:LUPIN.NS
2,104.6 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Lupin Limited |
Symbool | LUPIN.NS |
Munteenheid | INR |
Prijs | 2,104.6 |
Beurswaarde | 960,107,997,000 |
Dividendpercentage | 0.24% |
52-weken bereik | 1,153.55 - 2,312 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Vinita D. Gupta |
Website | https://www.lupin.com |
An error occurred while fetching data.
Over Lupin Limited
Lupin Limited, a pharmaceutical company, develops, produces, markets, and sells a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). It offers formulations for use in the therapeutic areas of cardiovascular, diabetology, asthma, pediatrics, central nervous system, gastrointestinal, anti-infective, nonsteroidal anti-inflammatory drug therapy, respiratory, women's health,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)